Highlights in colorectal cancer at ASCO GI 2023

0 Views

07/07/23

Stacey Cohen, MD, Fred Hutchinson Cancer Center, Seattle, WA, provides her highlights in the field of colorectal cancer at the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium, including advances in the use of ctDNA in clinical practice. Prospective data has demonstrated the versatility of ctDNA, and its ability to guide decision machining in clinical practice. This interview took place at the ASCO 2023 GI Symposium in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

View our new feature exploring genomic biomarkers in metastatic colorectal cancer here: https://bit.ly/3DcSevZ